{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:14:43Z","timestamp":1787238883272,"version":"build-2736575974"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"\n Importance<\/jats:title>\n No prospective epidemiologic studies have investigated genetic vs environmental factors on the risks of nevus-associated melanoma (NAM) and de novo melanoma.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine whether the risk factor profile differs for nevus-associated and de novo invasive melanoma, and whether the associations differ according to sex.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This population-based prospective cohort study (the QSkin Study) conducted in Queensland, Australia, included participants aged 40 to 69 years at baseline. Participants were recruited in 2011 and followed up until December 2022. All analyses were conducted between October 2024 and January 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Self-reported information from the baseline survey on phenotypic factors (hair color, tanning ability, nevus density, family history), sun exposure\u2013related factors (sunburns, history of skin cancers and actinic lesions), and polygenic risk scores for melanoma and nevus development was collected.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome and Measures<\/jats:title>\n The primary outcome was incident invasive melanoma (nevus-associated and de novo).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 17 752 males and 21 049 females were included and 859 were analyzed. During a median (IQR) follow-up of 11.4 (11.2-11.7) years, 209 participants developed an invasive nevus-associated melanoma (129 in males and 80 in females) and 650 developed an invasive de novo melanoma (362 in males and 288 in females). Many of the known phenotypic and sun exposure\u2013related risk factors for melanoma were similarly associated with nevus-associated and de novo melanoma, but high nevus density and high genetic propensity for melanoma development had significantly higher hazard ratios (HRs) for NAM than de novo melanoma (HR for many moles vs no moles, 6.86 [95% CI, 3.82-12.33] vs 3.21 [95% CI, 2.23-4.63];\n P<\/jats:italic>\n \u2009=\u2009.001; HR for melanoma polygenic risk score tertile 3 vs tertile 1, 6.46 [95% CI, 3.42-12.20) vs 2.98 [95% CI, 2.21-4.02];\n P<\/jats:italic>\n \u2009=\u2009.006). No significant differences in the risk factor profile for NAM were found for sex, but the HR for older age was significantly higher among males with de novo melanoma than in females. The site distribution of NAM differed for males and females, occurring mostly commonly on the trunk in males and on the limbs in females.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Results of this study identified distinct risk factor profiles for NAM and de novo melanomas, particularly polygenic risk and nevus propensity. Males and females tended to develop NAM on different body sites, which may have implications for early detection strategies.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamadermatol.2025.2004","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T15:00:38Z","timestamp":1752073238000},"page":"941","source":"Crossref","is-referenced-by-count":7,"title":["Risk Factors for Incident Nevus-Associated vs De Novo Invasive Melanoma"],"prefix":"10.1001","volume":"161","author":[{"given":"Catherine M.","family":"Olsen","sequence":"first","affiliation":[{"name":"Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"},{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja M.","family":"Shalit","sequence":"additional","affiliation":[{"name":"Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Pandeya","sequence":"additional","affiliation":[{"name":"Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"},{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Neale","sequence":"additional","affiliation":[{"name":"Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"},{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J. M. Shanika R.","family":"Jayasinghe","sequence":"additional","affiliation":[{"name":"Statistical Genetics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia"},{"name":"School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Law","sequence":"additional","affiliation":[{"name":"Statistical Genetics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia"},{"name":"School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia"},{"name":"School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Whiteman","sequence":"additional","affiliation":[{"name":"Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"},{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"doi250031r1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/jnci\/95.11.806","article-title":"Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.","volume":"95","author":"Whiteman","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"doi250031r2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway.","volume":"144","author":"Elder","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"doi250031r3","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/jdv.18453","article-title":"A review of nevus-associated melanoma: what is the evidence?","volume":"36","author":"Dessinioti","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"doi250031r4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jaad.2017.06.149","article-title":"A meta-analysis of nevus-associated melanoma: prevalence and practical implications.","volume":"77","author":"Pampena","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi250031r5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jamadermatol.2020.0470","article-title":"Evaluation of sex-specific incidence of melanoma.","volume":"156","author":"Olsen","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi250031r6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jid.2024.05.011","article-title":"Does sex matter? temporal analyses of melanoma trends among men and women suggest etiologic heterogeneity.","volume":"145","author":"Olsen","year":"2025","journal-title":"J Invest Dermatol"},{"issue":"5","key":"doi250031r7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/bjd\/ljae482","article-title":"Differences in mean age at diagnosis of invasive melanoma for men and women, by anatomic site, thickness, and subtype.","volume":"192","author":"Whiteman","year":"2025","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi250031r8","doi-asserted-by":"publisher","first-page":"MMT35","DOI":"10.2217\/mmt-2019-0019","article-title":"Genetics plays a role in nevi distribution in women.","volume":"7","author":"Visconti","year":"2020","journal-title":"Melanoma Manag"},{"key":"doi250031r9","article-title":"Body site-specific genetic effects influence naevus count distribution in women.","author":"Visconti","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"issue":"4","key":"doi250031r10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/ije\/dys107","article-title":"Cohort profile: the QSkin sun and health study.","volume":"41","author":"Olsen","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"10","key":"doi250031r11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/jnci\/djy023","article-title":"Risk stratification for melanoma: models derived and validated in a purpose-designed prospective cohort.","volume":"110","author":"Olsen","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"doi250031r12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jid.2018.09.022","article-title":"Association between phenotypic characteristics and melanoma in a large prospective cohort study.","volume":"139","author":"Olsen","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"2","key":"doi250031r13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/bjd.18703","article-title":"Does polygenic risk influence associations between sun exposure and melanoma? a prospective cohort analysis.","volume":"183","author":"Olsen","year":"2020","journal-title":"Br J Dermatol"},{"issue":"12","key":"doi250031r14","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jclinepi.2012.06.014","article-title":"Good test-retest reproducibility for an instrument to capture self-reported melanoma risk factors.","volume":"65","author":"Morze","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"doi250031r15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/1753-6405.13147","article-title":"\u201cRepeatability of Repeatability\u201d: the stability of self-reported melanoma risk factors in two independent samples.","volume":"45","author":"Mortimore","year":"2021","journal-title":"Aust N Z J Public Health"},{"issue":"5","key":"doi250031r16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41588-020-0611-8","article-title":"Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.","volume":"52","author":"Landi","year":"2020","journal-title":"Nat Genet"},{"issue":"2","key":"doi250031r17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1158\/1055-9965.EPI-12-1050","article-title":"A comparison of the polytomous logistic regression and joint cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies.","volume":"22","author":"Xue","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"doi250031r18","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1007\/s13555-022-00806-x","article-title":"Body site distribution of acquired melanocytic naevi and associated characteristics in the general population of caucasian adults: a scoping review.","volume":"12","author":"Jayasinghe","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"7","key":"doi250031r19","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw004","article-title":"Association of interferon regulatory factor-4 polymorphism rs12203592 with divergent melanoma pathways.","volume":"108","author":"Gibbs","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"doi250031r20","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/bjd.19705","article-title":"Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity.","volume":"184","author":"Laskar","year":"2021","journal-title":"Br J Dermatol"},{"issue":"6","key":"doi250031r21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/bjd\/ljae297","article-title":"Phenotypic and genotypic risk factors for invasive melanoma by sex and body site.","volume":"191","author":"Olsen","year":"2024","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi250031r22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jamadermatol.2022.4975","article-title":"Risk factors associated with first and second primary melanomas in a high-incidence population.","volume":"159","author":"Olsen","year":"2023","journal-title":"JAMA Dermatol"},{"key":"doi250031r23","unstructured":"QSkin: about the study. QIMR Berghofer. Accessed June 6, 2025. https:\/\/www.qimrb.edu.au\/studies\/qskin"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2836178\/jamadermatology_olsen_2025_oi_250031_1757438046.30335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:00:48Z","timestamp":1758121248000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2836178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2025.2004","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}